Core Viewpoint - Kunheng Shunwei (688283.SH) reported a decline in institutional ownership in its A-shares, with a total of 5 institutional investors holding 8.5342 million shares, representing 7.01% of the total share capital, a decrease of 0.31 percentage points from the previous quarter [1] Institutional Investors - As of August 25, 2025, the total shares held by institutional investors in Kunheng Shunwei amounted to 8.5342 million, accounting for 7.01% of the total share capital [1] - The institutional investors include Sichuan Development Securities Investment Fund Management Co., Ltd., Bank of China Co., Ltd., Guotai Jiatai Pension Product, Guotai Fund Management Co., Ltd., and Huayuan Qiyuan Future Mixed Initiation A [1] - The institutional ownership ratio decreased by 0.31 percentage points compared to the previous quarter [1] Public Funds - One new public fund disclosed its holdings in the current period, namely Huayuan Qiyuan Future Mixed Initiation A [1] - Three public funds that were previously disclosed did not report their holdings this quarter, including Fortune New Vitality Flexible Allocation Mixed A, Fortune Quality Growth 6-Month Holding Period Mixed A, and Hang Seng Qianhai High-End Manufacturing Mixed A [1] Social Security Funds - One new social security fund disclosed its holdings in Kunheng Shunwei, which is Guotai Fund Management Co., Ltd. - Social Security Fund 2103 Combination [1]

Core Viewpoint - Weir Pharmaceuticals (603351.SH) reported its semi-annual results for 2025, highlighting the current institutional investor holdings and changes in share ownership [1] Institutional Holdings - As of August 19, 2025, three institutional investors disclosed holding a total of 18.5823 million shares of Weir Pharmaceuticals, representing 13.72% of the company's total share capital [1] - The institutional holding percentage decreased by 0.66 percentage points compared to the previous quarter [1] Public Fund Holdings - Three public funds were disclosed this period, including Huaxia CSI 500 Index Enhanced A, Dongxing Lianzhong One-Year Holding Period Mixed A, and Dongxing Pharmaceutical Biotechnology Quantitative Stock Selection Mixed A [1] Social Security Fund Holdings - One new social security fund disclosed holding Weir Pharmaceuticals, namely Guotai Fund Management Co., Ltd. - Social Security Fund 2103 Portfolio [1] - One previously undisclosed social security fund, the National Social Security Fund 112 Portfolio, was also noted [1]